🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the safety and tolerance of the combination of adefovir dipivox...
Status
Completed
Location
Phoenix Body Positive
Start Date
TBD
Trial ID
NCT00002184
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
Drugs called checkpoint inhibitors help the immune system fight cancer. Whe...
Status
Active Not Recruiting
Location
Hartford Healthcare
Start Date
2018-10-01
Trial ID
NCT03693014
Treatments Being Tested
Rationale: Visual hallucinations (VH) are the most common non-motor symptom...
Status
Terminated
Location
Academic Medical Center
Start Date
2013-11
Trial ID
NCT01856738
Treatments Being Tested
To compare, in zidovudine (AZT)-naive patients, the safety, tolerance, and ...
Status
Completed
Location
Phoenix Body Positive
Start Date
TBD
Trial ID
NCT00002334
Treatments Being Tested
This study investigates the impact of perioperative inhibition of beta-adre...
Status
Recruiting
Location
The Chaim Sheba Medical Center
Start Date
2025-03-12
Trial ID
NCT06839144
Dyslipidemia is an independent risk factor for cardiovascular events. Stati...
Status
Unknown
Location
the first affiliated hospital of Harbin medical university
Start Date
2019-09-01
Trial ID
NCT03610321
Recent evidences suggest that zoledronate, one of the most used bisphosphon...
Status
Completed
Location
Azienda Socio Sanitaria Territoriale ASST Lariana - Presidio Ospedaliero Ospedale S. Anna
Start Date
2018-03-05
Trial ID
NCT03358017
Treatments Being Tested
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125